Thermo Fisher Scientific (TMO) Operating Expenses (2009 - 2026)

Thermo Fisher Scientific has disclosed Operating Expenses across 18 years of filings, most recently posting $9.1 billion for Q1 2026.

• Quarterly Operating Expenses rose 5.71% year-over-year to $9.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.3 billion (up 5.06% YoY) and the FY2025 annual result came in at $36.8 billion, up 3.57% from the prior year.
• Operating Expenses retreated to $9.1 billion in Q1 2026, from $10.0 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $10.0 billion in Q4 2025 and troughed at $8.6 billion in Q1 2025.
• A 5-year average of $9.1 billion and a median of $9.0 billion in 2025 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 31.21% — and 2023, when it dropped 5.81%.
• Tracing TMO's Operating Expenses over 5 years: stood at $9.6 billion in 2022, then dropped by 5.81% to $9.0 billion in 2023, then rose by 3.84% to $9.4 billion in 2024, then gained by 6.19% to $10.0 billion in 2025, then decreased by 8.21% to $9.1 billion in 2026.
• Business Quant data shows TMO's Operating Expenses at $9.1 billion in Q1 2026, $10.0 billion in Q4 2025, and $9.2 billion in Q3 2025.